Compare Abeona Therapeutics Inc (ABEO) vs Cloudflare Inc (NET) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Cloudflare Inc — how do they compare? Abeona Therapeutics Inc trades at $6.71 (market cap $373.32M), while Cloudflare Inc trades at $266.75 (market cap $95.42B). The key difference: Cloudflare Inc is far larger — about 255.6× Abeona Therapeutics Inc's market cap, and Cloudflare Inc is trading nearer its 52-week high, Abeona Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | NET | |
|---|---|---|
Market Cap | $373.32M | $95.42B |
Sector | Health | Technology |
52-Week High | $7.23 | $272.66 |
52-Week Low | $4.17 | $160.16 |
Enterprise Value | $228.22M | $94.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
NET trades at $268.77, up 11% today after Scotiabank upgraded the stock citing AI growth potential. The stock shows strong bullish momentum with a consensus analyst rating of 'Buy' (70% of 40 analysts) and a price target of $246.58. Recent earnings beats and revenue growth to $2.17B in 2025 highlight operational strength, though negative net margins and high valuations (P/S 37.22) pose challenges. Technical indicators signal bullish trends with resistance near $262.
Outlook: Growth driven by AI infrastructure demand and strategic partnerships offers upside, but high valuation and lack of profitability increase risk. Investors should weigh robust revenue growth against margin pressures and competitive threats in the cloud sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
